Paolo Grassi Selected Research

Paolo Grassi Research Topics

Disease

22	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2014
6	Neoplasms (Cancer) 10/2018 - 01/2014
5	Neoplasm Metastasis (Metastasis) 10/2018 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 11/2017 - 10/2015
4	Disease Progression 01/2020 - 10/2014
3	Kidney Neoplasms (Kidney Cancer) 10/2018 - 01/2014
2	Carcinoma (Carcinomatosis) 11/2017 - 09/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019
1	Circulating Neoplastic Cells 10/2018
1	Inappropriate ADH Syndrome (SIADH) 11/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2016
1	Heart Diseases (Heart Disease) 09/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2016
1	Enteritis 12/2014
1	Rectal Neoplasms (Rectal Cancer) 12/2014
1	Metrorrhagia (Spotting) 10/2014
1	Urachal adenocarcinoma 10/2014
1	Urachal cancer 10/2014
1	Primitive Neuroectodermal Tumors (PNET) 01/2014
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2014
1	Pulmonary Edema 01/2007
1	Dermatitis 03/2006

Drug/Important Bio-Agent (IBA)

5	Sorafenib (BAY 43-9006)FDA Link 11/2015 - 01/2014
4	pazopanib FDA Link 01/2020 - 11/2014
4	Tyrosine Kinase InhibitorsIBA 10/2018 - 05/2014
3	Everolimus FDA Link 03/2017 - 01/2014
3	Sunitinib (Sutent)FDA Link 11/2015 - 10/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 11/2015
2	cabozantinibIBA 12/2016 - 01/2016
2	NivolumabIBA 10/2016 - 09/2016
2	abirateroneIBA 09/2016 - 06/2016
2	Abiraterone AcetateIBA 09/2016 - 10/2015
2	Docetaxel (Taxotere)FDA Link 06/2016 - 10/2014
2	temsirolimus FDA Link 06/2015 - 04/2015
2	Capecitabine (Xeloda)FDA Link 12/2014 - 10/2014
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2014 - 10/2014
1	OsteopontinIBA 01/2020
1	E-SelectinIBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2020
1	Circulating Tumor DNAIBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	CytokinesIBA 10/2018
1	Vasopressins (Vasopressin)IBA 11/2017
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2017
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2016
1	LigandsIBA 10/2016
1	Monoclonal AntibodiesIBA 09/2016
1	Brentuximab VedotinIBA 09/2016
1	atezolizumabIBA 09/2016
1	pembrolizumabIBA 09/2016
1	Prednisone (Sone)FDA LinkGeneric 09/2016
1	Immune Checkpoint InhibitorsIBA 09/2016
1	Phosphotransferases (Kinase)IBA 06/2015
1	TOR Serine-Threonine KinasesIBA 06/2015
1	Proteins (Proteins, Gene)FDA Link 06/2015
1	XELOXIBA 12/2014
1	Soaps (Soap)IBA 11/2014
1	Cisplatin (Platino)FDA LinkGeneric 10/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2014
1	Axitinib (AG 013736)IBA 01/2014
1	Angiogenesis InhibitorsIBA 01/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014
1	Oxygen (Dioxygen)IBA 01/2007
1	Croton OilIBA 03/2006

Therapy/Procedure

14	Therapeutics 10/2018 - 06/2014
5	Nephrectomy 10/2018 - 01/2014
4	Drug Therapy (Chemotherapy) 01/2019 - 02/2014
4	Castration 10/2017 - 10/2015
1	Metastasectomy 10/2018
1	Combined Modality Therapy 12/2017
1	Brachytherapy 11/2017
1	Immunotherapy 09/2016
1	Time-to-Treatment 04/2015
1	Radiotherapy 12/2014